Lankisch P G, Thiele E, Mahlke R, Lübbers H, Riesner K
Department of Internal Medicine, Municipal Hospital, Lüneburg, Federal Republic of Germany.
Z Gastroenterol. 1990 May;28(5):247-50.
Recently, a high incidence of hepatic hematomas following percutaneous liver biopsy was reported. This induced us to undertake this prospective ultrasound examination before, as well as 2 and 24 h after, percutaneous liver biopsy, using a Menghini needle (O 1.4 mm), in 93 patients for diagnostic purposes. Two hours after biopsy a small subcapsular fluid margin was found in one patient (1.1%) which disappeared within 24 h. We conclude that hepatic hematomas are not frequent following percutaneous liver biopsy and that it remains a safe diagnostic procedure to find out the reason for chronically elevated liver enzymes and evaluate suspected diffuse parenchymal lesions of the liver.
最近,有报道称经皮肝穿刺活检后肝血肿的发生率较高。这促使我们对93例因诊断目的而采用Menghini针(外径1.4 mm)进行经皮肝穿刺活检的患者,在活检前、活检后2小时和24小时进行前瞻性超声检查。活检后2小时,1例患者(1.1%)发现小的包膜下液性边缘,该边缘在24小时内消失。我们得出结论,经皮肝穿刺活检后肝血肿并不常见,对于查明肝酶长期升高的原因以及评估肝脏疑似弥漫性实质病变而言,它仍是一种安全的诊断方法。